CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL)

Historical Holders from Q1 2014 to Q3 2025

Symbol: CRL on NYSE
Type / Class: Equity / Common Stock, $0.01 par value per share
Shares outstanding: 50,495,188
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 50,351,921
Holdings value: $7,913,577,421
% of all portfolios: 0.005%
Number of holders: 541
Number of buys: 278
Number of sells: -243
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	6.9%		$405,588,067		3,524,401		BlackRock, Inc.	31 Mar 2025
WELLINGTON MANAGEMENT GROUP LLP	6.5%	-23.8%	$499,180,467	-$171,252,511	3,190,467	-25.5%	Wellington Management Group LLP	30 Sep 2025
NOMURA HOLDINGS INC	1.6%	-76%	$126,407,633	-$293,166,299	807,923	-69.9%	NOMURA HOLDINGS INC	30 Sep 2025

Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	50,351,921	$7,913,577,421	-$82,168,885	$28,006,340	$31,464,106	$156.46	541
2025 Q2	50,888,032	$7,728,322,181	-$310,858,917	$215,199,040	$215,207,505	$151.73	512
2025 Q1	52,969,373	$7,965,191,033	-$132,450,866	$121,904,326	$104,693,740	$150.52	556
2024 Q4	52,965,520	$9,772,547,065	+$141,580,661	$44,152,124	$22,517,070	$184.6	629
2024 Q3	51,997,508	$10,237,704,172	+$106,573,857	$91,127,703	$51,062,530	$196.97	620
2024 Q2	52,315,867	$10,806,083,788	-$50,431,113	$48,752,880	$48,091,824	$206.58	652
2024 Q1	52,068,409	$14,099,205,526	+$83,751,736	$93,748,700	$49,448,375	$270.95	663
2023 Q4	51,907,726	$12,262,886,096	+$33,773,620	$74,158,680	$31,630,320	$236.4	626
2023 Q3	51,730,793	$10,129,283,110	+$137,477,111	$55,403,646	$36,667,858	$195.98	613
2023 Q2	51,052,211	$10,727,150,937	+$46,431,278	$27,032,907	$25,519,963	$210.25	606
2023 Q1	50,855,208	$10,257,550,518	+$230,104,905	$28,759,770	$24,882,294	$201.82	610
2022 Q4	49,950,724	$10,886,200,761	-$62,906,975	$28,678,720	$19,043,560	$217.9	616
2022 Q3	50,414,076	$9,921,902,851	+$280,780,236	$12,965,000	$27,653,000	$196.8	566
2022 Q2	48,746,360	$10,430,287,913	+$210,876,421	$21,499,000	$27,371,225	$213.97	612
2022 Q1	47,548,656	$13,504,739,634	+$68,014,953	$59,081,000	$38,125,000	$283.97	631
2021 Q4	47,053,533	$17,719,824,151	+$122,176,357	$55,415,000	$99,339,000	$376.78	696
2021 Q3	46,743,700	$19,292,102,147	-$322,317,303	$94,907,000	$118,922,000	$412.67	663
2021 Q2	47,485,940	$17,565,553,473	+$159,923,840	$83,504,920	$72,071,000	$369.92	626
2021 Q1	47,155,221	$13,665,037,431	+$124,076,612	$64,219,580	$42,511,000	$289.83	555
2020 Q4	46,852,548	$11,705,651,069	+$64,724,684	$48,372,500	$39,595,000	$249.86	533
2020 Q3	46,655,777	$10,562,682,947	+$28,508,177	$76,643,000	$110,256,000	$226.45	487
2020 Q2	50,866,401	$8,795,028,070	+$54,062,078	$57,106,000	$72,162,000	$174.35	457
2020 Q1	46,418,204	$5,859,212,569	-$77,502,036	$10,727,000	$28,273,000	$126.21	405
2019 Q4	46,958,559	$7,173,472,632	+$23,088,239	$9,451,000	$36,204,000	$152.76	403
2019 Q3	46,979,015	$6,218,760,306	+$100,248,974	$10,060,000	$9,493,000	$132.37	391
2019 Q2	46,156,461	$6,548,651,561	+$43,618,455	$14,147,000	$11,593,000	$141.9	398
2019 Q1	46,207,583	$6,703,515,424	+$124,731,562	$44,345,000	$16,094,000	$145.25	402
2018 Q4	45,431,938	$5,145,292,255	-$151,345,177	$5,466,000	$16,252,000	$113.18	401
2018 Q3	46,643,770	$6,271,366,247	+$95,417,101	$5,408,000	$15,002,000	$134.54	364
2018 Q2	46,298,815	$5,194,961,361	-$89,035,927	$1,885,000	$4,034,000	$112.26	345
2018 Q1	47,194,179	$5,032,045,297	+$8,653,634	$4,237,000	$4,428,000	$106.74	331
2017 Q4	47,238,705	$5,163,116,710	+$107,882,172	$2,080,000	$6,009,000	$109.45	338
2017 Q3	45,920,035	$4,960,436,852	-$9,151,703	$4,235,000	$1,567,000	$108.02	333
2017 Q2	45,975,742	$4,650,100,775	-$46,154,434	$2,297,000	$7,738,000	$101.15	300
2017 Q1	46,707,818	$4,201,206,531	+$352,124,245	$2,052,000	$1,619,000	$89.95	296
2016 Q4	46,202,771	$3,520,468,018	-$21,735,248	$472,000	$953,000	$76.19	294
2016 Q3	46,166,065	$3,844,365,949	+$20,498,550	$792,000	$15,481,000	$83.34	280
2016 Q2	46,125,327	$3,804,330,076	-$34,946,309	$1,026,000	$3,927,000	$82.44	279
2016 Q1	46,964,049	$3,568,493,897	+$146,096,438	$1,033,000	$2,855,000	$75.94	261
2015 Q4	45,023,951	$3,619,495,201	-$42,314,902	$1,190,000	$820,000	$80.39	263
2015 Q3	46,043,732	$2,924,569,828	-$38,255,873	$2,039,000	$711,000	$63.52	255
2015 Q2	46,642,392	$3,280,937,734	-$17,951,808	$2,701,000	$14,808,000	$70.34	259
2015 Q1	46,816,382	$3,709,872,590	+$59,266,038	$24,000	$856,000	$79.29	257
2014 Q4	46,271,208	$2,946,620,531	+$20,379,643	$394,000	$350,000	$63.64	250
2014 Q3	46,698,782	$2,789,816,513	-$86,471,529	$352,000	$5,956,000	$59.74	254
2014 Q2	48,221,369	$2,580,806,262	-$17,325,131	$69,000	$3,296,000	$53.52	260
2014 Q1	48,069,607	$2,899,195,114	+$73,553,910	$4,308,000	$5,442,000	$60.34	257